Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing …
LR Minces, MH Nguyen, D Mitsani… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Ganciclovir-resistant cytomegalovirus (CMV) infections are reported infrequently among
lung transplant recipients receiving extended valganciclovir prophylaxis. We performed a …
lung transplant recipients receiving extended valganciclovir prophylaxis. We performed a …
A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome
BACKGROUND: Cytomegalovirus (CMV) disease is a major cause of morbidity and mortality
after lung transplantation despite ganciclovir prophylaxis. The emergence of ganciclovir …
after lung transplantation despite ganciclovir prophylaxis. The emergence of ganciclovir …
The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation
RM Kruger, WD Shannon, MQ Arens, JP Lynch… - …, 1999 - journals.lww.com
Background. Cytomegalovirus (CMV) resistance to ganciclovir has become increasingly
common in acquired immu; nodeficiency syndrome patients but has only rarely been …
common in acquired immu; nodeficiency syndrome patients but has only rarely been …
Clinical impact of ganciclovir‐resistant cytomegalovirus infections in solid organ transplant patients
G Boivin, N Goyette, C Gilbert, A Humar… - Transplant infectious …, 2005 - Wiley Online Library
Clinical consequences of ganciclovir resistant cytomegalovirus (CMV) infections were
studied during 2 large prophylactic trials consisting of 100 days of valganciclovir or …
studied during 2 large prophylactic trials consisting of 100 days of valganciclovir or …
Subtherapeutic ganciclovir (GCV) levels and GCV‐resistant cytomegalovirus in lung transplant recipients
JP Gagermeier, JD Rusinak, NS Lurain… - Transplant Infectious …, 2014 - Wiley Online Library
Background Cytomegalovirus (CMV) infection results in significant morbidity and mortality in
lung transplant recipients. Ganciclovir (GCV) has dramatically reduced complications …
lung transplant recipients. Ganciclovir (GCV) has dramatically reduced complications …
Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients
SM Bhorade, NS Lurain, A Jordan, J Leischner… - The Journal of heart and …, 2002 - Elsevier
BACKGROUND: Since ganciclovir-resistant cytomegalovirus (CMV) disease was initially
described in a patient with acquired immunodeficiency syndrome (AIDS) in 1986, the …
described in a patient with acquired immunodeficiency syndrome (AIDS) in 1986, the …
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis
D Mitsani, MH Nguyen, EJ Kwak, FP Silveira… - The Journal of Heart and …, 2010 - Elsevier
BACKGROUND: Valganciclovir prophylaxis is advocated for lung transplant recipients, but
its efficacy is unknown. METHODS: Retrospective review was done of 109 donor …
its efficacy is unknown. METHODS: Retrospective review was done of 109 donor …
Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation
VG Valentine, D Weill, MR Gupta, B Raper… - The Journal of heart and …, 2008 - Elsevier
BACKGROUND: Universal ganciclovir (GCV) prophylaxis is a strategy aimed at reducing
cytomegalovirus (CMV) infection and delaying the development of bronchiolitis obliterans …
cytomegalovirus (CMV) infection and delaying the development of bronchiolitis obliterans …
High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy
Preemptive antiviral therapy in transplant patients is thought to be less likely to lead to
antiviral resistance than is routine prophylaxis. Cytomegalovirus (CMV)–seropositive lung …
antiviral resistance than is routine prophylaxis. Cytomegalovirus (CMV)–seropositive lung …
[HTML][HTML] Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection
L Cherrier, A Nasar, KJ Goodlet, MD Nailor… - American Journal of …, 2018 - Elsevier
Following a year of valganciclovir prophylaxis, a lung transplant recipient developed
cytomegalovirus (CMV) infection that became resistant to ganciclovir, as confirmed by …
cytomegalovirus (CMV) infection that became resistant to ganciclovir, as confirmed by …
相关搜索
- poor outcomes cytomegalovirus infections
- ganciclovir for cytomegalovirus lung transplantation
- transplant recipients cytomegalovirus resistance
- transplant recipients valganciclovir prophylaxis
- cytomegalovirus infection preemptive therapy
- cytomegalovirus infection letermovir resistance
- clinical impact cytomegalovirus infections
- cytomegalovirus infection high incidence
- cytomegalovirus infection lung transplantation